Abstract
Aspects of metabolism in prolactinomas were investigated by positron emission tomography using l-[1-11C]tyrosine, l-[methyl-11C]methionine and 18F-fluorodeoxyglucose (18FDG). Using l-[1-11C]tyrosine, four patients were monitored prior to and 18 h after an injection of 50 mg bromocryptine. At 18 h after bromocryptine intervention, l-[1-11C]tyrosine uptake into tumour was reduced with 28% (P<0.07). A correlation analysis of the bromocryptine-induced decrease in l-[1-11C]tyrosine uptake and the reduction of serum prolactin levels indicated that the action of bromocryptine on prolactin synthesis and prolactin release is not coupled. In the untreated situation, the four patients were investigated with 18FDG as well, but the prolactinomas could not be visualized. Three untreated patients were studied with l-[methyl-11C]methionine. The tumour-imaging potential of l-[methyl-11C]methionine and l-[1-11C]tyrosine appeared to be nearly equivalent for prolactinomas. Unlike prolactinoma tissue, the salivary glands showed a pronounced preference for l-[1-11C]tyrosine as compared to l-[methyl-11C]methionine. l-[1-11C]tyrosine is a valuable tool to obtain information on the metabolism and treatment of prolactinomas.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Arglebe C (1981) Biochemistry of human saliva. In: Pfaltz CR, Chilla R (eds) Advances in oto-rhino-laryngology, vol 26. Sialadenosis and Sialadenitis, pathophysiological and diagnostic aspects, Karger, Basel, pp 97–234
Battistone GC, Burnett GW (1961) The free amino acid composition of human saliva. Arch Oral Biol 3:161–170
Bergström M, Muhr C, Lundberg PO, Bergström K, Gee AD, Fasth K-J, Långström B (1987a) Rapid decrease in amino acid metabolism in prolactin-secreting pituitary adenomas after bromocryptine treatment: a PET study. J Comput Assist Tomogr 11:815–819
Bergström M, Lundqvist H, Ericson K, Lilja A, Johnström P, Långström B, Holst H von, Eriksson K, Blomqvist G (1987b) Comparison of the accumulation kinetics of l-(methyl-11C)-methionine and d-(methyl-11C)-methionine in brain tumors studied with positron emission tomography. Acta Radiol 28:389–393
Bergström M, Muhr C, Lundberg PO, Långström B (1988) Bromocryptine treatment reduces protein synthesis in prolactinomas in vitro. 5th International Congress on Prolactin, Kyoto, Japan, pp 171 (abstract P-120)
Bolster JM, Vaalburg W, Paans AMJ, Dijk ThH van, Elsinga PhH, Zijlstra JB, Piers DA, Mulder NH, Woldring MG, Wynberg H (1986) Carbon-11 labelled tyrosine to study tumor metabolism by positron emission tomography (PET). Eur J Nucl Med 12:321–324
Comar D, Cartron JC, Maziere M, Marazano C (1976) Labelling and metabolism of methionine-methyl-11C. Eur J Nucl Med 1:11–14
Daemen BJG, Paans AMJ, Elsinga PhH, Wieringa RA, Konings AWT, Vaalburg W (1989a) Hyperthermia induced suppression of protein synthesis in tumors as measured by PET. In: Schmidt HAE, Buraggi GL (eds) Nuclear medicine. Trends and possibilities in nuclear medicine. Schattauer, Stuttgart New York, pp 77–80
Daemen BJG, Elsinga PhH, Paans AMJ, Wieringa RA, Konings AWT, Vaalburg W (1989b) The effect of radiotherapy on l-[111C]tyrosine and 18FDG metabolism of tumors as measured by PET. J Nucl Med 30:789
Daemen BJG, Elsinga PhH, Ishiwata K, Paans AMJ, Vaalburg W (1991) A comparative PET study using different 11C-labelled amino acids in Walker 256 carcinosarcoma-bearing rats. J Nucl Med Biol 18:197–204
Davies JR, Sheppard MC, Heath DA (1990) Giant invasive prolactinoma: a case report and review of nine further cases. Quart J Med 275:227–238
Derlon J-M, Bourdet C, Bustany P, Chatel M, Therlon J, Darcel F, Syrota A (1989) [11C]l-methionine uptake in gliomas. Neurosurgery 25:720–728
Dollar JR, Blackwell RE (1986) Diagnosis and management of prolactinomas. Cancer Metastasis Rev 5:125–138
Di Chiro G (1986) Positron emission tomography using [18F]fluorodeoxyglucose in brain tumors: a powerful diagnostic and prognostic tool. Invest Radiol 22:360–371
Grossman A, Besser GM (1985) Prolactinomas. Br Med J 290: 182–184
Hamacher K, Coenen HH, Stöcklin G (1986) Efficient stereospecific synthesis of non-carrier added 2-[18F]-fluoro-2-deoxy-d-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med 27:235–238
Ishiwata K, Vaalburg W, Elsinga PH, Paans AMJ, Woldring MG (1988) Metabolic studies with l-[1-14C]tyrosine for the investigation of a kinetic model to measure protein synthesis rates with PET. J Nucl Med 29:524–529
Johansen PW, Haug E, Gautvick KM (1985) Effect of bromocryptine on hormone production and cell growth in cultured rat pituitary cells. Acta Endocrinol 110:200–206
Keen RE, Barrio JR, Huang S-C, Hawkins RA, Phelps ME (1989) In vivo cerebral protein synthesis rates with leucyl-transfer RNA used as a precursor pool: determination of biochemical to structure tracer kinetic models for positron emission tomography J Cereb Blood Flow Metab 9:429–445
Lilja A, Lundqvist H, Olsson Y, Spännare B, Gullberg P, Långström B (1989) Positron emission tomography and computed tomography in differential diagnosis between recurrent or residual glioma and treatment-induced brain lesions. Acta Radiol 30:121–128
Maurer RA (1980) Dopaminergic inhibition of prolactin synthesis and prolactin messenger RNA accumulation in cultured pituitary cells. J Biol Chem 255:8092–8097
Maurer RA (1981) Transcriptional regulation of the prolactin gene by ergocryptine and cyclic AMP. Nature 294:94–97
Minn H, Joensuu H, Ahonen H, Klemi P (1988) Fluorodeoxyglucose imaging: a method to assess the proliferative activity of human cancer in vivo. Comparison with DNA flow cytometry in head and neck tumors. Cancer 61:1776–1781
Muhr C, Bergström M, Lundberg PO, Bergström K, Hartvig P, Lundqvist H, Antoni G, Långström B (1986) Dopamine receptors in pituitary adenomas: PET visualization with 11C-N-methylspiperone. J Comput Assist Tomogr 10:175–180
Niwa J, Minase T, Mori M, Hashi K (1987) Immunohistochemical, electron microscopic, and morphometric studies of human prolactinomas after short-term bromocryptine treatment. Surg Neurol 28:339–344
Paans AMJ, Vaalburg W, Woldring MG (1985) A rotating double-headed positron camera. J Nucl Med 26:1466–1471
Patronas NJ, Di Chiro G, Brooks RA, DeLaPaz RL, Kornblith PL, Smith BH, Rizzoli HV, Kessler RM, Manning RG, Channing M, Wolf AP, O'Connor CM (1983) Work in progress:[18F]fluorodeoxyglucose and positron tomography in the evaluation of radiation necrosis of the brain. Radiology 144:885–889
Schober O, Meyer G-J, Duden C, Lauenstein L, Niggemann J, Müller J-A, Gaab MR, Becker H, Dietz H, Hundeshagen H (1987) Uptake of amino acids in brain tumors using positron emission tomography as an indicator for assessing metabolic activity and malignancy. Fortschr Röntgenstr 147:503–509
Shome B, Farlow AF (1977) Human pituitary prolactin (hPRL): the entire linear amino acid sequence. J Clin Endocrinol Metab 45:1112–1115
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Daemen, B.J.G., Zwertbroek, R., Elsinga, P.H. et al. PET studies with l-[1-11C]tyrosine, l-[methyl-11C]methionine and 18F-fluorodeoxyglucose in prolactinomas in relation to bromocryptine treatment. Eur J Nucl Med 18, 453–460 (1991). https://doi.org/10.1007/BF00181283
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00181283